Reimbursement summary for angioplasty of arteries of lower extremities with stenting using bare metal and drug-eluting stents

This post presents an extract from our reimbursement analysis for angioplasty of arteries of lower extremities with stenting using bare metal and drug-eluting stents for peripheral arterial disease in England, France and Germany. 

Angioplasty with stenting using bare metal stents is reimbursed via combination of diagnosis-related group (DRG) and add-on reimbursement in England and France and solely via DRG in Germany:

• In England, add-on reimbursement is organized via generic categories of peripheral vascular stents in the High Cost Device List
• In France, add-on reimbursement is available via LPPR title III using either generic code or brand-specific codes for Abbott Vascular’s Xpert, Xpert Pro and CID’s Inperia Advance Carbostent
• In Germany, angioplasty with stenting using bare metal stents is reimbursed solely via DRG. DRG and reimbursement tariff depends on number of stents inserted (one, two or three and more)

Angioplasty with stenting using drug-eluting stents is reimbursed in a similar way via combination of diagnosis-related group (DRG) and add-on reimbursement in England and France and solely via DRG in Germany:

• In England, procedure using DES is grouped into Healthcare Resource Group (HRG, English version of DRG) with higher tariff, compared with HRG for procedure using bare metal stent. Add-on reimbursement is organized via generic categories of peripheral vascular stents in the High Cost Device List
• In France, add-on reimbursement is available via LPPR title III brand-specific codes for Cook Medical’s Zilver PTX, Abbott Vascular’s Xience Prime BTK and four Boston Scientific’s Promus family stents
• In Germany, angioplasty with stenting using DES is reimbursed via exactly the same DRGs as procedure using BMS

Purchase our complete reimbursement report to get complete overview of reimbursement situation for this procedure in 11 European countries.

Subscribe to our biweekly newsletter not to miss important reimbursement information.